Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	338.18	44.81	10.23
Graham Fair Price	8.46	7254.77	6688.62
PEG	-21.94	0.43	-0.55
Price/Book	10.74	1.01	0.91
Price/Cash Flow	19.84	66.67	55.63
Prices/Earnings	-4.82	7.27	7.64
Price/Sales	12.86	12.79	11.33
Price/FCF	19.84	66.67	55.63
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-5.69	0.19	0.21
Operating Margin	-3.33	0.11	0.12
ROA	16.08	0.03	0.03
ROE	0.03	0.03	16.34
ROIC	< 0.005	< 0.005	-3.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-1.00	0.18	462.98
Dividends QOQ	8.58	-0.90	-89.53
EBIT QOQ	0.32	-0.05	-85.38
EPS QOQ	-0.14	0.17	21.93
FCF QOQ	-0.33	-0.07	78.30
Revenue QOQ	0.11	-0.01	-87.33
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	103.91	104.59	0.65
Days Sales Outstanding (DSO)	74.12	68.35	-7.79
Inventory Turnover	0.87	0.86	-0.65
Debt/Capitalization	0.00	0.00	0.00
Quick Ratio	13.29	13.35	0.44
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	8162.12	8207.68	0.56
Cash	4486.14	4799.46	6.98
Capex	-19.61	-45.49	-132.03
Free Cash Flow	133.76	124.29	-7.08
Revenue	656.65	647.89	-1.33
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	12.77	12.33	-3.44
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-9.13	-36.57	-300.41
Naive Interpretation	Member

06 - Financial Health · Bad

Rating